CSPC Pharmaceutical Group Limited — Earnings Release 2003

Aug 12, 2003

Listed Company Information

CHINA PHARMA<01093> - Results Announcement (Summary) China Pharmaceutical Group Limited announced on 12/08/2003: (stock code: 01093 ) Year end date: 31/12/2003 Currency: HKD Auditors' Report: N/A Review of Interim Report by: Both Audit Committee and Auditors (Unaudited ) (Unaudited ) Last Current Corresponding Period Period from 01/01/2003 from 01/01/2002 to 30/06/2003 to 30/06/2002 Note ($ ) ($ ) Turnover : 1,360,282,000 705,193,000 Profit/(Loss) from Operations : 437,521,000 130,619,000 Finance cost : (14,575,000) (12,725,000) Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : 3,050,000 4,081,000 Profit/(Loss) after Tax & MI : 359,361,000 101,161,000 % Change over Last Period : +255 % EPS/(LPS)-Basic (in dollars) : 0.2392 0.0812 -Diluted (in dollars) : 0.2343 0.08 Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : 359,361,000 101,161,000 Interim Dividend : 7.00 cents NIL per Share (Specify if with other : N/A N/A options) B/C Dates for Interim Dividend : 01/09/2003 to 05/09/2003bdi. Payable Date : 26/09/2003 B/C Dates for (-) General Meeting : N/A Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remarks: 1. Profit from operations For the six months ended June 30, 2003 2002 HK$ HK$ Profit from operations has been arrived at after charging (crediting): Allowance for bad and doubtful debts - 5,450,000 Amortisation of intangible assets 6,873,000 7,566,000 Depreciation of property, plant and equipment 63,111,000 47,359,000 Bank interest income (774,000) (480,000) ================================= 2. Earnings per share The calculation of the basic and diluted earnings per share is based on the following data: For the six months ended June 30, 2003 2002 Profit attributable to shareholders HK$359,361,000 HK$101,161,000 ================================== Weighted average number of ordinary shares for the purposes of basic earnings per share 1,502,212,661 1,245,580,163 Effect of dilutive potential ordinary shares in respect of share options 31,350,946 19,661,140 --------------------------------- Weighted average number of ordinary shares for the purposes of diluted earnings per share 1,533,563,607 1,265,241,303 ================================